HOME > LATEST
LATEST
-
BUSINESS Padcev/Keytruda Wins US Nod for Perioperative Bladder Cancer Use
November 26, 2025
-
BUSINESS Otsuka Files Novel ADHD Drug Centanafadine in US
November 26, 2025
-
BUSINESS Novartis Eyes Broader Radioligand Therapy Footprint in Japan as Pluvicto Debuts
November 26, 2025
-
BUSINESS Eisai to Unify Global HR Framework by 2029 to Bolster Leqembi Growth
November 25, 2025
-
BUSINESS Marubeni Pharma Targets Doubling Profits by FY2035 with 2 New Deals Each Year
November 25, 2025
-
REGULATORY LDP, Ishin Start Framing Copay Models for OTC-Like Drugs: Bilateral Talks
November 25, 2025
-
BUSINESS Sanofi Seeks Age 60+ Access as Japan Plans NIP Addition of Efluelda for 75+
November 25, 2025
-
BUSINESS Kyowa Kirin Begins Japan PIII Trial of Infigratinib for Achondroplasia
November 25, 2025
-
BUSINESS Expert Expects New 21-Valent Pneumococcal Shot Capvaxive to Curb Invasive Disease
November 25, 2025
-
REGULATORY Label Updated for Gazyva and Imbruvica: PMDA
November 25, 2025
-
BUSINESS Otsuka’s Hypercholesterolemia Med Nexletol Hits Japan Shelves
November 25, 2025
-
REGULATORY Japan Finalizes Economic Package Positioning Pharma as “Core Industry”
November 25, 2025
-
REGULATORY Local Legislators Urge Routine HPV Shots for Males as LDP Group Renews Push
November 25, 2025
-
REGULATORY Japan to Launch Panel Next Year to Discuss Third-Party Access to Vaccination Database
November 25, 2025
-
REGULATORY Japan to Revise Guidance on Standards for Biological Raw Materials
November 25, 2025
-
REGULATORY Patient Groups Push Back against Delisting OTC-Like Drugs; Panel Leans Toward Higher Copays
November 21, 2025
-
REGULATORY Japan Approves Label Expansions for Braftovi, Augtyro, Uplizna, and More
November 21, 2025
-
REGULATORY Japan Panel OKs NIP Use of Maternal RSV Vaccine from FY2026
November 21, 2025
-
REGULATORY Japan to Add High-Dose Flu Vaccine to NIP for Adults Aged 75 and Over
November 21, 2025
-
BUSINESS Towa, Sawai Log H1 Sales Gains, but Overseas Woes and Litigation Drag on Profit
November 21, 2025
ページ
The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…
